Olin and Huntsman shareholders clear $12.5bn chemicals merger as regulatory test moves to centre stage

Olin Corporation (NYSE: OLN) and Huntsman Corporation (NYSE: HUN) have cleared the shareholder hurdle for their planned all-stock merger of equals, moving a combination expected to create a chemicals company with approximately US$12.5 billion of pro forma 2025 revenue into its regulatory and integration phase. Preliminary voting results show approximately 97% of votes cast by Olin shareholders supported the transaction, while approximately 99% of votes cast by Huntsman stockholders backed the merger.

Support was broad even when measured against total outstanding ownership rather than only votes cast. The Olin votes in favour represented approximately 81% of all outstanding shares, while the supporting Huntsman votes represented approximately 75% of outstanding stock. Those results are sufficient for the companies to proceed through the direct-merger structure contemplated by their agreement rather than the alternative subsidiary-merger mechanism that had been included in the transaction documents.

Shareholder approval removes a major uncertainty from a deal announced in June, but it does not complete the combination. Olin and Huntsman continue to expect closing during the first half of 2027, subject principally to required regulatory approvals and satisfaction or waiver of other customary conditions. The next phase therefore shifts attention away from whether investors support the strategic thesis and toward whether regulators allow the proposed integration to proceed on the timetable management expects.

How will the Olin-Huntsman all-stock merger divide ownership of the combined company?

Under the definitive agreement, Huntsman shareholders are to receive 0.5476 Olin shares for each Huntsman share they own. When the merger closes, existing Olin shareholders are expected to own approximately 54.5% of OlinHuntsman Corporation, while Huntsman shareholders will hold approximately 45.5%.

The structure is consequently much closer to a strategic merger of equals than a conventional cash takeover in which one company pays a fixed acquisition price and assumes most of the transaction risk. Both shareholder groups remain exposed to the combined company’s future operating performance, realization of synergies, chemical-market cycles and integration decisions after closing.

OlinHuntsman is expected to be headquartered in The Woodlands, Texas. Olin President and Chief Executive Officer Ken Lane is slated to become chief executive officer of the combined company, while Huntsman Chairman, President and Chief Executive Officer Peter Huntsman is expected to become non-executive chairman.

The ownership split also makes the synergy programme particularly important because neither shareholder group receives cash that crystallizes value at closing. The economic outcome will instead depend substantially on whether management can improve the earnings capacity and cash generation of the combined platform sufficiently to justify the dilution and integration risk accepted by both sides.

Why are more than $400m of expected synergies central to the OlinHuntsman investment case?

Olin and Huntsman have identified more than US$400 million of annual cost synergies and integration benefits. More than US$300 million is expected from near-term purchasing, operational and administrative savings, with more than 90% of that amount targeted within the first 24 months after closing. Another US$100 million-plus of annual raw-material integration benefits is expected beginning in 2031 as existing supply arrangements at Huntsman’s Geismar, Louisiana, site expire.

The near-term programme is relatively specific. Approximately US$75 million is expected from purchasing and raw-material integration, another US$75 million from operating efficiencies and global asset optimization, and about US$150 million from selling, general and administrative savings including elimination of duplicative corporate costs.

Those figures show why the merger cannot be evaluated merely by adding Olin and Huntsman’s existing earnings together. The companies estimate that their businesses would have generated approximately US$12.5 billion of combined 2025 revenue and about US$1.3 billion of pro forma adjusted EBITDA when expected cost synergies are included.

More than US$400 million of eventual annual benefits therefore represents roughly 31% of the US$1.3 billion pro forma adjusted EBITDA figure that already includes the expected synergies. Looked at another way, the transaction thesis depends on management adding an earnings contribution that is large relative to the pre-synergy profitability of the two companies.

That creates both opportunity and execution risk. Corporate overhead savings can generally be pursued soon after closing, while plant optimization, feedstock integration and supply-chain changes involve more complex operational decisions. The additional US$100 million-plus expected from 2031 is even further removed from closing and depends on management successfully restructuring raw-material flows after existing contracts expire.

How is vertical integration supposed to improve OlinHuntsman’s chemical economics?

The strategic argument is built around joining Olin’s upstream manufacturing and feedstock positions with Huntsman’s more downstream chemical products and formulation expertise. Management believes the combination can internalize value that currently passes between separate suppliers and customers while improving the economics of several important chemical chains.

One example is Huntsman’s amines business. The companies expect integration with Olin’s ethylene dichloride and caustic soda production to improve Huntsman’s cost position and potentially make the combined operation one of the lower-cost producers in the global performance-amines market. The strategy would simultaneously provide additional internal demand for Olin feedstocks.

A similar argument applies to polyurethanes. Huntsman’s MDI production can potentially benefit from integration with Olin’s chlor-alkali position, allowing the combined company to capture economics at more stages of the chain rather than buying or selling intermediate products entirely through external markets.

Management also sees an opportunity between Olin’s epoxy operations and Huntsman’s Advanced Materials business. Internalizing more of that value chain could improve margins and create additional downstream growth opportunities if the companies can coordinate production, pricing and customer requirements effectively.

These potential revenue benefits are not included in the disclosed US$400 million synergy target, making them theoretical upside rather than part of the quantified base case. That distinction matters because investors should be able to judge the merger initially against the cost savings management has explicitly committed to rather than assuming all cross-selling and vertical-integration opportunities will materialize.

What do Olin and Huntsman’s latest results say about the timing of the merger?

The shareholder vote arrives when neither company is operating in an exceptionally easy chemical environment. Olin reported second-quarter sales of US$1.742 billion, down slightly from US$1.758 billion a year earlier, and a net loss of US$13.3 million. Adjusted EBITDA nevertheless improved to US$191.3 million from US$176.1 million.

Olin’s quarter was also affected by an unplanned outage at its vinyl chloride monomer facility in Freeport, Texas, which management estimated reduced second-quarter adjusted EBITDA by approximately US$40 million. The company expected another roughly US$20 million impact during the third quarter before operations returned to full rates.

Huntsman generated second-quarter revenue of US$1.663 billion and adjusted EBITDA of US$120 million, compared with US$74 million a year earlier. The company reported a US$6 million attributable net loss and used US$90 million of free cash flow during the quarter, reflecting the continued volatility affecting chemical manufacturers.

Taken together, the two companies generated about US$3.4 billion of second-quarter revenue and approximately US$311 million of adjusted EBITDA, although those simple sums are not pro forma merger results and do not account for accounting differences, eliminations or future integration effects.

The operating backdrop makes the merger rationale more understandable. Management is seeking scale, lower structural costs and greater internal sourcing at a point when energy costs, raw-material volatility, global competition and uneven end-market demand continue to pressure the sector.

It also raises the stakes. Synergy programmes are easiest to describe before companies combine; they become more difficult when management simultaneously has to stabilize plants, defend market share, manage working capital and integrate thousands of employees and manufacturing assets across multiple regions.

What regulatory and execution hurdles remain before OlinHuntsman can close?

The companies have not characterized the August 25 vote as the final transaction condition. Required regulatory approvals remain outstanding, and the expected first-half 2027 closing timetable assumes those reviews can be completed without conditions that materially change the economics of the merger.

The combination creates a large vertically integrated chemicals supplier with positions spanning chlor-alkali, vinyls, epoxies, polyurethanes, advanced materials, amines and other industrial chemicals. Regulators evaluating large chemical combinations typically examine overlaps, customer alternatives and supply-chain consequences in relevant product markets, although the ultimate scope and outcome of the reviews in this transaction remain to be determined.

Even after regulatory clearance, integration will be a multi-year exercise. The companies expect more than 90% of the US$300 million-plus near-term synergy programme within two years of closing, meaning much of the cost restructuring would have to be undertaken during 2027 through 2029 if the current schedule holds.

The later raw-material integration opportunity stretches further. More than US$100 million of additional benefits is expected beginning in 2031, several years after the merger itself is planned to close.

Shareholders have now made their position unusually clear. Approximately 97% of votes cast at Olin and 99% at Huntsman supported the combination. The debate around OlinHuntsman consequently moves to a more demanding phase: whether regulatory approvals arrive on schedule and whether a US$400 million-plus synergy thesis can be converted from transaction mathematics into sustainable cash earnings.